Steatotic liver disease risk scores compared for predicting cirrhosis
For patients with steatotic liver disease (SLD), the steatosis-associated fibrosis estimator (SAFE) score demonstrated the greatest net benefit for predicting cirrhosis, according to a study published online Sept. 21 in JAMA Internal Medicine.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Virtual reality and classical music help to reduce blood pressure in patients in emergency department
United Kingdom
-
Drones could speed up delivery of automated external defibrillators to patients suffering cardiac arrest
United Kingdom
-
Tapping the power of cryo-ET to visualize how molecular machines interact inside cells
United Kingdom
-
UC researcher receives funding to study bone complications in people with sickle cell disease
United Kingdom
-
Aga's restaurant in Houston is number one in the world for Uber Eats deliveries
United States
-
UM birding program can help stroke survivors with aphasia
United Kingdom
-
Existing drug helps bladder cells destroy hidden urinary tract infections
United Kingdom
-
New pre-hospital blood test reduces unnecessary emergency department visits for chest pain
United Kingdom